Articles Published in 2008

Encorium Appoints New CEO, Replaces Borow

Monday, February 25, 2008 11:05 AM

Wayne, Pa.-based Encorium Group has appointed Kai Lindevall, M.D., Ph.D., as chief executive officer, replacing president and CEO, Kenneth Borow, M.D.

More... »

CWWeekly February 18th 2008 Issue

Friday, February 22, 2008 11:47 AM

Top News

More... »

eClinical Technology News

Thursday, February 21, 2008 10:04 AM

• Cleveland, Ohio-based Datatrak inked an enterprise agreement for at least $800,000, depending on the extent of services required by the client. The agreement is a three-year subscription license with an unnamed pharmaceutical company in Europe. The model is a contracting mechanism for the company’s platform is a separate option to its “trial by trial” model. Datatrak stated its typical “revenue composition” has been 25% for the technology element of an eClinical implementation and 75% for services. “We believe that we will always have the trial-by-trial business model, because this is more appropriate for clients with smaller pipelines. However, for clients with more predictable and larger pipelines, this model provides very predictable research and development costs and eliminates wasted time involved with negotiation and contracting under the trial-by-trial mode,” stated Jeffery Green, Pharm.D., chief executive officer of Datatrak.

More... »

Parexel Courts ClinPhone with Takeover Bid

Wednesday, February 20, 2008 10:02 AM

UK-based eClinical company ClinPhone rejected a preliminary takeover offer from Parexel International,  a contract research organization (CRO) based in Waltham, Mass.

More... »

CenterWatch Monthly February 2008 Issue

Friday, February 15, 2008 03:22 PM

Site Training on EDC Improves

More... »

CWWeekly February 11th 2008 Issue

Friday, February 15, 2008 12:32 PM

Top News

More... »

Ketek Hearing Winners and Losers

Wednesday, February 13, 2008 04:09 PM

After listening to the Feb. 12th hearing by the House Energy and Commerce’s Subcommittee on Oversight and Investigations probing study fraud and the antibiotic Ketek, one thing is clear: PPD, which monitored the study in question sponsored by Aventis (now Sanofi-Aventis), took the least hits from Congress. And it is also quite clear that many in Congress, including committee staff, don’t seem to understand much about the research process.

More... »

Trial Results for Psoriasis Drug Ustekinumab Hit Mark

Wednesday, February 13, 2008 02:15 PM

Centocor reported one year data from a phase III trial of ustekinumab (CNTO-1275), a monoclonal antibody against the p40 subunit of IL-12 and IL-23 for the treatment of moderate to severe plaque psoriasis. This randomized, double-blind, placebo-controlled trial, dubbed PHOENIX-1, enrolled 766 subjects.

More... »

Revolutionary Public-Private Partnership for Early Phase Trials Established in France

Tuesday, February 12, 2008 01:09 PM

The Centre Hospitalier Universitaire (CHU) de Caen, a university teaching hospital and the largest hospital in the West of France, and Therapharm, a large, private contract research organization founded in 1980, have joined forces to form the first public-private partnership to conduct early phase clinical research in France. The clinical research center is called Centre de Recherche Clinique-Basse Normandie (CRC-BN). The center conducts phase I and II clinical trials that are industry-sponsored, investigator-initiated and government-sponsored.

More... »

Veritas Medicine Restructures Business, Drops Trial Listing Service

Monday, February 11, 2008 11:28 AM

Cambridge, Mass.-based Veritas Medicine, a clinical trial services company, has discontinued its patient recruitment services and laid off a number of employees.

More... »